Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
SION-109 by Sionna Therapeutics for Cystic Fibrosis: Likelihood of Approval
SION-109 is under clinical development by Sionna Therapeutics and currently in Phase I for Cystic Fibrosis. According to GlobalData, Phase...